Application of Antiosteoporosis Therapy in Osteolysis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHenan Cancer Hospital
About this trial
To report the postoperative complications and limb function of patients with osteolysis after surgery for bone tumors of the extremities who received anti-osteoporosis therapy in Henan Cancer Hospital in the next 10 years.
Eligibility criteria
Qualifiers
No age restriction, male or female.
A subtype of bone tumor (including benign, malignant, and metastatic cancer) was confirmed in the pathology department of the research institution.
Received excision of bone tumor in research institution.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Anti-osteoporosis therapy
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov